Japan Grants Conditional Approval to the World's First iPS Cell Therapies for Parkinson's Disease and Heart Failure
Japan's health ministry has conditionally approved two iPS cell-derived drugs, marking the first time regenerative medicines built from induced pluripotent stem cells will reach patients commercially.
5 min read4 sources